Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10075-10087
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10075
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10075
Table 3 The incidence of hand-foot syndrome, n (%)
| HFS occurrence | |||||
| No HFS | Grade 1 | Grade 2 | Z | P value | |
| Control group | 30 (60.0) | 19 (38.0) | 1 (2.0) | 4.686 | 0.000003 |
| Cooling group | 50 (98.0) | 1 (2.0) | 0 (0.0) | ||
- Citation: Zheng YF, Fu X, Wang XX, Sun XJ, He XD. Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients. World J Clin Cases 2021; 9(33): 10075-10087
- URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10075.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10075